We are live on
!
Find out more
FI
FCM Investments Portfolio holdings
AUM
$70.1M
1-Year Est. Return
98.98%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+98.98%
3 Year Est. Return
+210.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$131M
AUM Growth
-$27.7M
(-17%)
Cap. Flow
-$33.2M
Cap. Flow
% of AUM
-25.35%
Top 10 Holdings %
Top 10 Hldgs %
69.97%
Holding
86
New
–
Increased
–
Reduced
26
Closed
38
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.63M |
| 2 |
Intuitive Surgical
ISRG
|
+$3.08M |
| 3 |
Cisco
CSCO
|
+$2.98M |
| 4 |
Verisk Analytics
VRSK
|
+$2.47M |
| 5 |
CELG
Celgene Corp
CELG
|
+$2.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.22% |
| 2 | Communication Services | 21.94% |
| 3 | Healthcare | 20.28% |
| 4 | Industrials | 3.39% |
| 5 | Energy | 3.13% |
Similar funds
YCM
MIM
HC
KCM
PSW
IT
AZA
SIA
FCM Investments's Q2 2017 Portfolio in Review
As of Q2 2017, FCM Investments held 86 positions worth $131M, down 17% from $159M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
FCM Investments withdrew a net $33.2M in Q2 2017, closing 38 positions and reducing 26 holdings. Its most notable exit was Gilead Sciences, an estimated $3.63M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Communication Services and Healthcare.
- FCM Investments's biggest Q2 2017 reduction was Intuitive Surgical, cutting an estimated $3.08M.
- FCM Investments fully exited Gilead Sciences in Q2 2017, selling an estimated $3.63M.
- FCM Investments's ten largest holdings make up 70% of its $131M portfolio in Q2 2017.
- FCM Investments opened 0 new positions and closed 38 in Q2 2017.
- FCM Investments's portfolio value fell 17% quarter-over-quarter to $131M.
Based on FCM Investments's 13F filing for Q2 2017, filed 28 Jul 2017.